Forum Replies Created
- Replies
-
-
- June 10, 2014 at 4:16 pm
Thank you very much for the thorough analysis of the research presented. My concern, as always, is the fact that no meta analysis seems to take place outside of ASCO. In a twist of irony, I was diagnosed with BRCA2 breast cancer 2 years after my husband's recurrent melanoma was diagnosed. One of the many cancers listed of which I now have an increased risk for getting in my lifetime is melanoma, so the poster showing the connection between pregnancy and melanoma didn't seem shocking to me. I hope that more information is shared across disciplines and specialties, as this will continue to offer a broad and thorough approach to attacking cancer, particularly on the genetic level.
-
- June 10, 2014 at 4:16 pm
Thank you very much for the thorough analysis of the research presented. My concern, as always, is the fact that no meta analysis seems to take place outside of ASCO. In a twist of irony, I was diagnosed with BRCA2 breast cancer 2 years after my husband's recurrent melanoma was diagnosed. One of the many cancers listed of which I now have an increased risk for getting in my lifetime is melanoma, so the poster showing the connection between pregnancy and melanoma didn't seem shocking to me. I hope that more information is shared across disciplines and specialties, as this will continue to offer a broad and thorough approach to attacking cancer, particularly on the genetic level.
-
- June 10, 2014 at 4:16 pm
Thank you very much for the thorough analysis of the research presented. My concern, as always, is the fact that no meta analysis seems to take place outside of ASCO. In a twist of irony, I was diagnosed with BRCA2 breast cancer 2 years after my husband's recurrent melanoma was diagnosed. One of the many cancers listed of which I now have an increased risk for getting in my lifetime is melanoma, so the poster showing the connection between pregnancy and melanoma didn't seem shocking to me. I hope that more information is shared across disciplines and specialties, as this will continue to offer a broad and thorough approach to attacking cancer, particularly on the genetic level.
-